Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.55 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.55 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.55 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | AHR | P35869 | 1/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.40 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3456349 | 1.00 | NPC1 (0.55) | NPC1MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL9056376 | 0.84 | AHR (0.53) | NPC1MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL9056372 | 0.84 | AHR (0.53) | NPC1MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL2216919 | 0.81 | NPC1 (0.47) | NPC1MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL9056394 | 0.76 | NPC1 (0.64) | NPC1MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL2086488 | 0.74 | NPC1 (0.62) | NPC1MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL9372759 | 0.74 | NPC1 (0.52) | NPC1MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL6469101 | 0.73 | NPC1 (0.72) | NPC1MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL3458619 | 0.72 | LRRK2 (0.48) | MAPTALDH1A1CYP1A2CYP2C19KMT2A | |
| SCHEMBL407439 | 0.72 | NPC1 (0.70) | NPC1MAPK13MAPK12MAPK11MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1345908-B1 | PROCESS FOR THE PREPARATION OF ALPHA-AMINOSUBSTITUTED CARBOXYLIC ACID AMIDES | MERCK PATENT GMBH (DE) | 2011-07-27 | — | — | EP | disclosed |
| EP-2256104-A1 | Process for the preparation of alpha-aminosubstituted carboxylic acid amides | Merck Patent GmbH (DE) | 2010-12-01 | — | — | EP | disclosed |
| US-7166720-B2 | Process for the preparation of α-aminosubstituted carboxylic acid amides | MERCK PATENT GESELLSCHAFT (DE) | 2007-01-23 | — | — | US | disclosed |
| US-7053211-B2 | Process for the preparation of α-aminosubstituted carboxylic acid amides | MERCK PATENT GMBH (DE) | 2006-05-30 | — | — | US | disclosed |
| US-20060025587-A1 | Process for the preparation of alpha-aminosubstituted carboxylic acid amides | HARTIG THORSTEN | 2006-02-02 | — | — | US | disclosed |
| US-20040034250-A1 | Process for the preparation of alpha-aminosubstituted carboxylic acid amides | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2004-02-19 | — | — | US | disclosed |
| EP-1345908-A2 | PROCESS FOR THE PREPARATION OF ALPHA-AMINOSUBSTITUTED CARBOXYLIC ACID AMIDES | MERCK PATENT GmbH (DE) | 2003-09-24 | — | — | EP | disclosed |
| WO-2002051813-A2 | PROCESS FOR THE PREPARATION OF α-AMINOSUBSTITUTED CARBOXYLIC ACID AMIDES | MERCK PATENT GMBH (DE) | 2002-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040034250-A1 | Process for the preparation of alpha-aminosubstituted carboxylic acid amides | ASNS, HNMT, NAAA | NPC1 4246/4885MAPK13 3000/4885MAPK12 2388/4885 |
| US-20060025587-A1 | Process for the preparation of alpha-aminosubstituted carboxylic acid amides | ASNS, HNMT, AASDHPPT | NPC1 4088/4885MAPK13 3195/4885MAPK12 2412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.